ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

INCIDENCE OF HIT (HEPARIN INDUCED THROMBOCYTO-PENIA) AFTER THE MYOCARDIUM CURED WITH LOW-SLUNG MOLECULAR WEIGHT ANTI-CLOTTING AGAINST UN-FRACTIONED ANTI-CLOTTING

Dr. Faiza Ashraf, Dr. Mujahid Hussain, Dr. Tariq Aziz

Objective: The research was held to find out the regularity of HIT (heparin induced thrombocyte-penia) with un-fractioned anti-clotting against low-slung molecular weight anti-clotting use after the myocardium. Study Design: CCS (Case control study). Place and Duration of Study: This study was held for the duration of two years from June, 2016 to June, 2018 at Punjab Cardiology Hospital, Lahore. Method: Patients who were selected for this research particular low-slungmolecular weight anti-clotting or un-fractionated anti-clotting, which shows with myocardium. Data was recorded on the base of age, gender, diagnosis, history of revelation to un-fractioned anti-clotting, the time of on-set of low platelet count and the type of anti-clotting controlled. The thrombocyte-penia of all selected patients was tested on daily basis. Experimental recording was executed for the opportunity of HIT (heparin induced thrombocyte-penia). The data was evaluated by using SPSS 20. Results: The regularity of anti-clotting in general thrombocyte-penia was 3.2%. In the group of 02 patients showing to UFH and LMWH, there was noted a huge deviation in the regularity of heparin-induced thrombocyte-penia. Conclusion: Our research concludes that the risk of anticoagulant medication is decreased with the use of undivided anti-clotting. Key words: HIT (heparin-induced thrombocyte-penia), less molecular weight anticoagulant, non-fractionated anticoagulant medication.

FULL TEXT